Scripta

[Scripta @scriptainsights]

Prozac (fluoxetine) is a safe, effective drug that has given millions of patients relief from symptoms of major depression. But why are the tablets more expensive than the capsules? #bigpharma #genericdrugs #drugpricing

[Scripta @scriptainsights]

Inspiration for this post > https://t.co/Pw6q0CEhA2

[Scripta @scriptainsights]

Even CVS Caremark has realized that constant, consistent oversight is the only way to address "hyperinflated" drug prices. Scripta has been doing it for years. Read more on our blog >> https://t.co/17WdAzgIzu

[Scripta @scriptainsights]

Said co-founder Mindy Bradley: “We want to make sure we give kudos to @HHSGov for giving it a go. Drug coupons play havoc with our best efforts at balancing cost sustainability and getting members the drugs they need, and for years only a few of us were taking them into account.”

[Scripta @scriptainsights]

The government issued a confusing new ruling designed to curb the use of drug manufacturer coupons, and then delayed implementation until 2021. We feel their pain. https://t.co/LMDUsVODYj

[Scripta @scriptainsights]

"...Studies show that a given coupon will put a significant dent in the percentage of prescriptions filled with a generic competitor, and that, as a result, coupons actually increase drug spending.” https://t.co/8XchD3PF1F

[Scripta @scriptainsights]

At Scripta, we believe that “talk to your doctor” is THE opportunity for benefits managers and others hoping to get pharmacy costs under control.

[Scripta @scriptainsights]

A new study tells us that Medicare and its beneficiaries could have saved an estimated $17.7 billion earlier this decade on generic versions of older medicines instead of paying for newer, chemically similar but more expensive brand-name drugs like Nexium https://t.co/rtTwNscqPS

[Scripta @scriptainsights]

What happened? The key, of course, is awareness — by controlling the conversation we have in the doctor’s office, Big Pharma is able to sell us drugs we don’t need at prices we can’t afford.

[Scripta @scriptainsights]

"Pharmacy benefit managers (PBMs) have the authority to trump a doctor’s medical judgement without seeing patients or knowing their full medical history, and without accountability for the consequences of what happens to sick people." https://t.co/DluRqyUGGO

[Eugene Gu, MD @eugenegu]

As a physician, it’s infuriating that CVS Caremark believes Pharmacy Benefit Managers can override a doctor’s urgent plan to give chemotherapy to a patient with Stage 3 multiple myeloma. CVS thinks policies and profits come before human lives. #CVSCareLess https://t.co/fmnbO1X0E9

[Scripta @scriptainsights]

AARP believes that it is time for Congress to take action to protect seniors and all taxpayers from price gouging by drug companies. Tell your legislators to support commonsense solutions to lower prescription drug prices today!

[Scripta @scriptainsights]

Nearly three-quarters of Americans over 50 worry about being able to afford prescription drugs for themselves and their families, according to a new AARP nationwide survey >> https://t.co/6UXmPXRgoX

[Scripta @scriptainsights]

The only way to stay ahead of Big Pharma's games is to become better, more informed consumers. That means giving plan members the tools to make decisions that save them money, while at the same time saving money for the plan overall.

[Scripta @scriptainsights]

Authorized generics offer a number of competitive advantages for drug makers - among them - they usually aren’t subject to rebates that flow from the drugmaker to middlemen. The shell game continues: https://t.co/CSROxLG1vs

[Scripta @scriptainsights]

Source for our latest blog post: https://t.co/rJYAtby6YL

[The Phia Group, LLC @ThePhiaGroup]

As you all know, The Phia Group is always looking for ways to lower the cost of healthcare for employers and employees. That being said, we are proud to announce that we have partnered up with Scripta! This partnership will help ensure our employees are ge https://t.co/ETXgXRfI1d

[Scripta @scriptainsights]

Read about the era of million-dollar drugs on our blog: As expensive gene therapies become available, concerns among payers and physicians turn to cost sustainability. From our blog >>> https://t.co/UrkOT797uh

[Scripta @scriptainsights]

FDA: Novartis, maker of expensive gene therapy, manipulated data before drug was approved. Inspiration for our new blog post... https://t.co/uCFo9iKI5t